A 68-year-old man with chronic heart failure due to ischaemic cardiomyopathy (LVEF 35%) is stable but breathless on exertion. He is currently taking Ramipril but no other heart failure medication. According to NICE guidance, which additional drug class should be introduced first to improve prognosis?